Clinical Trials Directory

Trials / Unknown

UnknownNCT05816018

Improving Health Care in Major Depressive Disorder

Improving Health Care in Major Depressive Disorder: a New Prognostic Tool Based on Gene Environment and Neuroimaging Signatures

Status
Unknown
Phase
Study type
Observational
Enrollment
30,900 (estimated)
Sponsor
Ospedale San Raffaele · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

This project aims to improve the health care provided to people with major depressive disorder (MDD), a disease which is a top cause of disability worldwide. One of the main obstacles to a more effective health care in these patients is represented by clinical heterogeneity, which has not completely elucidated biological correlates. Using a large sample of people with MDD already recruited (n=29,400), the investigators develop a clustering algorithm based on genetic-environmental and brain imaging predictors aimed at identifying homogeneous MDD subgroups. The researchers will then link these subgroups with relevant health outcomes, such as disease recurrency and severity, well-being and functioning, risk of psychiatric and medical comorbidities (e.g. cardiovascular disorders). Replication in independent samples already recruited(n=1380) will prove the validity of the subgroups and expand their clinical characterization. The investigators will develop a classification tool to link the individual's characteristics to the relevant health outcomes and provide corresponding clinical recommendations. The prognostic support tool will be applied to newly recruited samples, feasibility and usefulness according to clinicians's opinion will be assessed (n=120, ongoing recruitment).

Conditions

Timeline

Start date
2021-10-12
Primary completion
2025-06-15
Completion
2025-06-15
First posted
2023-04-18
Last updated
2023-04-18

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05816018. Inclusion in this directory is not an endorsement.